Business and People April 2014
Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
People
• TrialNetworks (Needham, MA) announced the addition of Jose G. Guerra, MD, as Advisory Board Chairman. Guerra has been in the global biopharmaceutical industry for more than 30 years, including 24 years at Merck & Co.
• ICON plc, (Dublin, Ireland) announced the appointment of Dariush Elahi, PhD, as Director of Metabolic Research. Based in ICON's Clinical Pharmacology Unit in San Antonio, TX. Elahi will lead ICON's early phase glucose clamping programs globally.
• INC Research (Camberley, UK) announced the appointment of two senior executives to its team. Asli Turkes, PhD, has joined as Vice President, Clinical Development, Oncology. Susan Timoney, PhD, has joined as Executive Director, Clinical Development, Oncology. INC also announced the addition of Beatrice Setnik, PhD, as Vice President, Clinical Pharmacology; and Jane Winter as Senior Vice President of its Global Consulting Unit.
• Covance (Princeton, NJ) announced that Barry J. Goldstein, MD, PhD, has joined its Clinical Development Services business as Vice President and Global Therapeutic Area Head of the expanded Cardiovascular, Metabolic, and Scientific Affaris leadership team.
• Vetter Development Services USA, Inc. (Chicago, IL) announced that President Claudia Roth, PhD, was elected to the board of the Illinois Biotechnology Industry Organization.
Claudia Roth
• CluePoints (Cambridge, MA) announced three new appointments to its global team. John Colby and Elizabeth Polvent join the company's US Business Development Team. Jean Stéphenne, President of the Board of Directors of GlaxoSmithKline Biologicals, was welcomed as a member of the board.
John Colby
• Synergy Research Group, (St. Petersburg, Russia) a Russia-based CRO, announced that John Barker has joined the company as COO.
• Novella Clinical, (Stevenage, England) a Quintiles company, announced the addition of Chris Smyth, PhD, MBA, as their new Managing Director of European and Asian Operations.
Chris Smyth
• The European Federation of Pharmaceutical Industries and Associations (EFPIA) (Brussels, Belgium) announced Liam English as its new Communications Director.
• Exco InTouch (Sawbridgeworth, UK) announced the appointment of Laurence Burke as Vice President of Operations.
• CTI Clinical Trial and Consulting Services (CTI) (Cincinnati, OH) announced the addition of Shelly Brewer as Director, Global Safety and Pharmacovigilance.
Shelly Brewer
Awards
• ERT (Philadelphia, PA) announced that Philadelphia SmartCEO has recognized the company in its Future 50 Awards program. The program recognizes the region's fastest-growing mid-sized and large Blue Chip companies that have experienced outsized growth based on a combined three-year average of revenue and employee growth.
• Pharmaceutical Product Development, LLC (PPD) (Wilmington, NC) announced the company was ranked among the top US businesses for employee learning and development by Training magazine. The recognition marks the third consecutive ranking for PPD on the annual Training Top 125 list.
• DAC Patient Recruitment Services (Dallas, TX) announced that it took home the gold in the 2014 AVA Digital Awards competition of writing, design, and execution of its DACTracks digital marketing campaign.
• Forte Research Systems, Inc. (Madison, WI) announced that the Research Resonance Network received the Clinical Informatics News Best Practices Award in the category of Clinical Data Intelligence. The Research Resonance Network—which was developed through collaboration with research organizations and offers free tools for continuous improvement—was recognized for its standards-based approach to improving clinical research operations.
• CTI Clinical Trial and Consulting Services (CTI) (Cincinnati, OH) was named Blue Ash Corporation of the Year by the Cincinnati USA Regional Chamber. The award recognizes outstanding companies in one of Cincinnati USA's most vibrant business communities.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
